Insider · CIK 0001327442

Fickenscher James E

Reports to the SEC for 3 companies · MALVERN, PA

sec.gov

Transactions

Companies

Filings

CIK

0001327442

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-10-10	Zynerba Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−125K sh	—	—	0
2023-10-10	Zynerba Pharmaceuticals, Inc.U Disposition from Tender	Chief Financial Officer	UDisposition from Tender	−123K sh	—	—	255,000
2023-10-10	Zynerba Pharmaceuticals, Inc.A Award	Chief Financial Officer	AAward	+170K sh	—	—	425,000
2023-10-10	Zynerba Pharmaceuticals, Inc.U Disposition from Tender	Chief Financial Officer	UDisposition from Tender	−425K sh	—	—	0
2023-09-13	Zynerba Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−8,998 sh	$1.33	−$11.9K	378,087
2023-09-12	Zynerba Pharmaceuticals, Inc.A Award	Chief Financial Officer	AAward	+31.2K sh	—	—	387,085
2023-02-08	Zynerba Pharmaceuticals, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−6,544 sh	$0.60	−$3,903.496	355,885
2023-02-07	Zynerba Pharmaceuticals, Inc.A Award	Chief Financial Officer	AAward	+22.5K sh	—	—	362,429
2023-02-01	Zynerba Pharmaceuticals, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−5,927 sh	$0.60	−$3,527.75	339,882
2023-01-31	Zynerba Pharmaceuticals, Inc.A Award	Chief Financial Officer	AAward	+21.1K sh	—	—	345,809
2023-01-24	Zynerba Pharmaceuticals, Inc.A Award	Chief Financial Officer	AAward	+170K sh	—	—	324,736
2023-01-23	Zynerba Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−17.8K sh	$0.60	−$10.6K	154,736
2022-07-19	Zynerba Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−6,013 sh	$1.10	−$6,614.3	172,505
2022-07-18	Zynerba Pharmaceuticals, Inc.A Award	Chief Financial Officer	AAward	+20.8K sh	—	—	178,518
2022-01-26	Zynerba Pharmaceuticals, Inc.A Award	Chief Financial Officer	AAward	+85K sh	—	—	157,718
2022-01-26	Zynerba Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+125K sh	—	—	125,000
2021-01-21	Zynerba Pharmaceuticals, Inc.A Award	Chief Financial Officer	AAward	+52K sh	—	—	72,718
2021-01-21	Zynerba Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+78K sh	—	—	78,000
2020-01-30	Zynerba Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+85K sh	—	—	85,000
2019-01-24	Zynerba Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+88.1K sh	—	—	88,099
2018-08-06	Zynerba Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+8,518 sh	$5.97	+$50.8K	20,718
2018-01-11	Zynerba Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+67.5K sh	—	—	67,500
2017-05-12	Zynerba Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+5,200 sh	$19.82	+$103K	12,200
2017-01-25	Zynerba Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+31.4K sh	—	—	31,350
2016-12-07	Zynerba Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+4,000 sh	$14.03	+$56.1K	7,000
2016-12-06	Zynerba Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+3,000 sh	$14.15	+$42.5K	3,000
2016-09-13	Zynerba Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+150K sh	—	—	150,000
2016-06-02	ANTARES PHARMA, INC.Stock option (right to buy)A Award	Senior Vice President & CFO	AAward	+258K sh	—	—	257,900
2016-06-02	ANTARES PHARMA, INC.A Award	Senior Vice President & CFO	AAward	+121K sh	$1.12	+$136K	391,266
2016-03-18	ANTARES PHARMA, INC.P Purchase	Senior Vice President & CFO	PPurchase	+135K sh	$0.72	+$97.2K	270,216
2015-05-28	ANTARES PHARMA, INC.A Award	Senior Vice President & CFO	AAward	+95.2K sh	—	—	135,216
2015-05-28	ANTARES PHARMA, INC.Stock option (right to buy)A Award	Senior Vice President & CFO	AAward	+193K sh	—	—	193,241
2015-03-10	ANTARES PHARMA, INC.Stock option (right to buy)A Award	Senior Vice President & CFO	AAward	+10K sh	—	—	10,000
2014-12-11	ANTARES PHARMA, INC.P Purchase	Senior Vice President & CFO	PPurchase	+40K sh	$2.50	+$99.8K	40,000
2014-11-20	ANTARES PHARMA, INC.Stock option (right to buy)A Award	Senior Vice President & CFO	AAward	+150K sh	—	—	150,000
2014-02-18	AUXILIUM PHARMACEUTICALS INCA Award	Chief Financial Officer	AAward	+6,375 sh	—	—	49,351
2014-02-18	AUXILIUM PHARMACEUTICALS INCA Award	Chief Financial Officer	AAward	+15K sh	—	—	63,683
2014-02-18	AUXILIUM PHARMACEUTICALS INCF Tax Payment	Chief Financial Officer	FTax Payment	−668 sh	$28.30	−$18.9K	48,683
2014-02-18	AUXILIUM PHARMACEUTICALS INCA Award	Chief Financial Officer	AAward	+15K sh	—	—	63,683
2014-02-18	AUXILIUM PHARMACEUTICALS INCNonqualified Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+37K sh	—	—	37,000
2014-02-18	AUXILIUM PHARMACEUTICALS INCRestricted Stock Units (Performance Based)A Award	Chief Financial Officer	AAward	+24K sh	—	—	24,000
2014-02-07	AUXILIUM PHARMACEUTICALS INCF Tax Payment	Chief Financial Officer	FTax Payment	−2,156 sh	$23.68	−$51.1K	42,976
2013-12-11	AUXILIUM PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−71.1K sh	—	—	0
2013-12-11	AUXILIUM PHARMACEUTICALS INCM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+71.1K sh	$4.78	+$340K	116,199
2013-12-11	AUXILIUM PHARMACEUTICALS INCS Sale	Chief Financial Officer	SSale	−71.1K sh	$20.37	−$1.45M	45,132
2013-06-21	AUXILIUM PHARMACEUTICALS INCF Tax Payment	Chief Financial Officer	FTax Payment	−80 sh	$17.15	−$1,372	45,132
2013-02-07	AUXILIUM PHARMACEUTICALS INCA Award	Chief Financial Officer	AAward	+3,940 sh	—	—	30,494
2013-02-07	AUXILIUM PHARMACEUTICALS INCF Tax Payment	Chief Financial Officer	FTax Payment	−482 sh	$18.30	−$8,820.6	45,212
2013-02-07	AUXILIUM PHARMACEUTICALS INCNonqualified Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+37.5K sh	—	—	37,500
2013-02-07	AUXILIUM PHARMACEUTICALS INCA Award	Chief Financial Officer	AAward	+15.2K sh	—	—	45,694

Recent filings

Accepted (ET)
Oct 114
Fickenscher James E0001140361-23-047742
SEC(opens sec.gov)
Sep 144
Fickenscher James E0001062993-23-018020
SEC(opens sec.gov)
Feb 94
Fickenscher James E0000899243-23-004444
SEC(opens sec.gov)
Feb 24
Fickenscher James E0000899243-23-003726
SEC(opens sec.gov)
Jan 254
Fickenscher James E0001062993-23-001386
SEC(opens sec.gov)
Jul 204
Fickenscher James E0001062993-22-016556
SEC(opens sec.gov)
Jan 284
Fickenscher James E0001062993-22-001785
SEC(opens sec.gov)
Jan 254
Fickenscher James E0001192482-21-000114
SEC(opens sec.gov)
Feb 34
Fickenscher James E0001192482-20-000087
SEC(opens sec.gov)
Jan 284
Fickenscher James E0001192482-19-000048
SEC(opens sec.gov)

Companies

Address

C/O AUXILIUM PHARMACEUTICALS, INC 40 VALLEY STREAM PARKWAY

MALVERN, PA, 19355